Oviva Therapeutics is focused on developing innovative therapeutics aimed at enhancing ovarian function and extending the healthspan of women. The company recognizes that the decline in ovarian function, which occurs earlier than aging in other tissues, significantly impacts women's overall health and well-being. By targeting the ovarian reserve—the finite number of eggs a woman has—Oviva aims to mitigate the adverse health outcomes associated with menopause, such as cardiovascular disease, osteoporosis, and cognitive decline. Their approach is grounded in rigorous, evidence-based medicine, emphasizing the importance of ovarian health as a critical factor in women's longevity.

A key component of Oviva's strategy involves the use of Anti-Müllerian Hormone (AMH), which plays a vital role in regulating the ovarian reserve and folliculogenesis. The company is advancing a recombinant AMH program, which has shown promise in pre-clinical studies for enhancing ovarian function, particularly in women who are poor responders to in vitro fertilization (IVF). By synchronizing follicles and increasing egg quantity, this therapeutic could significantly improve fertility outcomes and potentially delay menopause, thereby extending women's healthspan. Oviva's commitment to addressing the gaps in women's health research positions it as a pioneer in the field, with the potential to transform how ovarian health is understood and managed.

United States

Oviva is a premier biotech company developing first-in-class therapeutics to improve ovarian function and consequently extend female healthspan. Oviva is leading a movement to improve women’s experience of aging through biomedical research, clinical development and advocacy. While driving tangible progress through therapeutics programs, Oviva is engaging with scientists, clinicians, policy makers and the general public to elevate, and equalize, the conversation around women’s health. In bringing together stakeholders across disciplines, we are inviting diverse perspectives and skill sets to drive innovation and progress in this space.

Oviva Therapeutics

Company Details